预测肿瘤学的大胆飞跃：人工智能，数字资产和国库策略革命

预测肿瘤学（POAI）通过潜入数字资产，特别是Aethir（ATH）令牌，旨在促进AI驱动的药物发现并建立战略性计算储备，从而震撼了生物技术。

Yo, what's up, Wall Street watchers! Predictive Oncology (POAI) is making waves, blending AI-driven cancer research with a bold digital asset treasury strategy. This ain't your grandma's biotech play.

哟，怎么了，华尔街观察家！预测肿瘤学（POAI）正在引起浪潮，将AI驱动的癌症研究与大胆的数字资产库策略融为一体。这不是您奶奶的生物技术。

POAI's $344 Million Crypto Gamble: A Breakdown

POAI的3.44亿美元加密赌博：故障

Predictive Oncology, a Pittsburgh-based company focused on using AI to accelerate cancer drug discovery, just priced two private placements totaling a cool $344 million. The kicker? They're diving headfirst into digital assets, with Aethir (ATH) tokens leading the charge.

一家总部位于匹兹堡的公司预测肿瘤学致力于使用AI加速癌症药物发现，刚刚定价了两个私人位置，总计3.44亿美元。踢球？他们首先跳入数字资产，而Aethir（ATH）令牌领导了这一指控。

Here’s the deal:

这是交易：

• Cash Infusion: Roughly $52 million raised through stock sales.
• Crypto Swap: A hefty $293 million in Aethir tokens for pre-funded warrants.

The plan is simple: amass ATH tokens to fuel their AI computing needs and create a Strategic Compute Reserve. Aethir, for those not in the know, runs a decentralized GPU network, offering AI computing power at prices that undercut the big cloud providers.

该计划很简单：Amass Ath代币可以促进其AI计算需求并创建战略性计算储备。对于那些不认识的人来说，Aethir运营着一个分散的GPU网络，以削弱大云提供商的价格提供AI计算能力。

Why Aethir? The GPU Gold Rush

为什么是艾西尔？ GPU淘金热

Aethir isn't just another crypto fad. It's a network providing crucial GPU resources for AI development. Predictive Oncology is betting that as AI demand skyrockets, so will the value of ATH tokens. Plus, POAI gets a 20% bonus in ATH tokens for every purchase they make, creating a virtuous cycle.

Aethir不仅是另一种加密时尚。这是一个为AI开发提供重要的GPU资源的网络。预测性肿瘤学押注，随着AI的需求Skyrockets，ATH令牌的价值也会如此。另外，Poai在他们进行的每次购买中都会在ATH令牌中获得20％的奖励，从而创造出良好的周期。

Strategic Compute Reserve: More Than Just Hype

战略计算储备：不仅仅是炒作

CEO Raymond Vennare calls this move a "seminal event," aiming to supercharge POAI's core business while tapping into AI's future. Aethir’s co-founder Dan Wang envisions a “world’s first Strategic Compute Reserve.” This isn't just about holding tokens; it's about powering the Aethir network and securing access to essential AI infrastructure.

首席执行官雷蒙德·维纳尔（Raymond Vennare）称这一举动为“开创性事件”，旨在在利用AI的未来的同时增强POAI的核心业务。 Aethir的联合创始人Dan Wang设想了“世界上第一个战略计算储备”。这不仅仅是持有令牌；这是关于为Aethir网络提供动力并确保获得基本AI基础架构的访问。

The Bigger Picture: Biotech Meets Blockchain

大局：生物技术遇到区块链

AI is hungry for computing power, and companies that can bridge healthcare with cutting-edge tech are positioned for major wins. Predictive Oncology's AI platform already boasts a 92% accuracy in predicting drug response in tumors. Adding a crypto treasury is like strapping a rocket to a sports car, and could rewrite how medical breakthroughs are funded and fueled.

AI渴望计算能力，可以将医疗保健桥接的公司定位为重大胜利。预测肿瘤学的AI平台已经在预测肿瘤的药物反应方面具有92％的精度。添加加密货币就像将火箭绑在跑车上，并且可以重写医疗突破的资金和加油方式。

Potential and Pitfalls: A Reality Check

潜力和陷阱：现实检查

Let's be real—there are risks. Crypto is volatile, ATH's value depends on Aethir's success, and issuing new shares dilutes existing holdings. But the potential rewards are significant. If Aethir takes off, POAI's ATH holdings could multiply, funding drug discovery without bleeding shareholders dry. Plus, they've got Wall Street heavyweights like H.C. Wainwright backing them.

让我们成为现实 - 有风险。 Crypto是波动的，ATH的价值取决于Aethir的成功，并发行新股份稀释了现有的持股。但是潜在的奖励很大。如果Aethir起飞，Poai的Ath Holdings可能会繁殖，从而在不流血股东干燥的情况下资助毒品。另外，他们还有华尔街重量级人物，例如HC Wainwright支持他们。

Final Thoughts: Eyes on the Future

最终想法：注视未来

Predictive Oncology's dive into digital assets is a bold move that could redefine the intersection of biotech and AI. It's a high-stakes game with potentially massive rewards. Keep your eyes peeled, folks, because this is one wild ride you don't want to miss!

预测肿瘤学进入数字资产是一个大胆的举动，可以重新定义生物技术和AI的交集。这是一款高风险的游戏，并具有巨大的回报。伙计们，请睁大眼睛，因为这是您不想错过的一次狂野旅程！